Q4 2025
Released Jun 1, 2026, after the close
10-K filed Jun 1, 2026, 152 days after period end · 0000868278-26-000005
Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$784.00K$784.00K derived−47.5% vs Q4 2024−11.2% vs Q3 2025
Net Income-$7.40M-$7.40M derivedN/M vs Q4 2024N/M vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$247,000N/M
Operating Incomederived-$5,726,000N/M
Operating Cash Flowderived-$1,230,000N/M
Free Cash Flowderived-$1,230,000N/M
Margins · derived
Gross margin31.5%+41.5 pt vs Q4 2024
Operating margin-730.4%+426.9 pt vs Q4 2024
Net margin-943.6%+1356.2 pt vs Q4 2024
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $784.00K | $1.49M | — | $21.82M |
| Net Income | -$7.40M | -$34.36M | -$8.75M | -$2.45M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR